Superior Group of Companies Earnings Call Transcripts
Fiscal Year 2026
-
Three diversified segments—healthcare apparel, branded products, and contact centers—drove strong revenue growth and customer retention, supported by robust financials and strategic use of AI. The company is focused on acquisitions, cost efficiency, and expects revenue growth across all segments in 2026.
Fiscal Year 2025
-
Fourth quarter results showed modest revenue growth and nearly doubled EPS, driven by strong Branded Products performance and disciplined cost control. 2026 guidance anticipates up to 3% revenue growth and significant EPS improvement, with all segments expected to contribute as macro conditions stabilize.
-
Third quarter revenue declined 7% year-over-year, but sequential improvement and strong cost controls led to higher net income versus Q2. Branded Products and Healthcare Apparel faced macro headwinds, while robust pipelines and a tightened full-year outlook signal optimism for future growth.
-
Three diversified segments—healthcare apparel, branded products, and contact centers—drive growth, with strong dividends, active buybacks, and robust AI adoption. Macro uncertainty and tariffs have impacted demand, but Q2 saw strong results and margin improvement is expected across all segments.
-
Three diversified segments—healthcare apparel, branded products, and contact centers—drove strong growth, with revenues reaching $566 million and robust customer retention. AI integration, cost-saving initiatives, and expanding sales teams position the company for continued growth and margin improvement.
-
Q2 saw over 9% revenue growth year-over-year, led by Branded Products and Healthcare Apparel, with net income per share rising to $0.10. Cost controls, AI adoption, and strategic sourcing offset macro headwinds, while full-year guidance remains unchanged at $550–$575 million.
-
Three diversified segments—healthcare apparel, branded products, and contact centers—drive growth through digital expansion, high customer retention, and strategic capital allocation. Revenue and profitability are up, with strong liquidity, ongoing share repurchases, and a stable dividend.
-
Revenue was nearly flat year-over-year, with a net loss per share of $0.05 due to lower gross margins and sales mix. Full-year revenue guidance was lowered amid tariff and macro uncertainty, but strong pipelines and cost reductions position the business for improved profitability as conditions normalize.
-
Three diversified segments delivered $566 million in 2024 sales, with strong growth in Contact Centers and Branded Products. Strategic capital allocation supports dividends, buybacks, and M&A, while AI adoption and a resilient supply chain position the business for continued expansion.
-
Three business segments—branded products, healthcare apparel, and contact centers—drive growth, with AI and innovation central to operations. Financial priorities include dividends, share buybacks, and targeted M&A, while margin strength and market share gains are supported by strategic investments and risk management.
Fiscal Year 2024
-
Full-year revenue grew 4% and EPS rose 35% year-over-year, while Q4 revenue dipped 1% amid tough comps. 2025 guidance calls for up to 5% revenue and 12% EPS growth, with a gradual, back-end weighted build expected.
-
Third quarter saw record revenues and strong margin expansion, driven by double-digit growth in healthcare apparel and branded products, while contact centers grew modestly but faced margin pressure. Full-year guidance is reaffirmed, with continued investments in talent and technology to support long-term growth.
-
Three business segments—branded products, healthcare apparel, and contact centers—are pursuing growth through technology, new sales channels, and targeted acquisitions. Recent supply chain issues have been addressed, and capital allocation remains focused on dividends, organic investment, and M&A. AI and automation are key to operational efficiency and customer value.
-
Superior Group operates in healthcare apparel, branded products, and contact centers, each showing strong growth and high customer retention. 2023 revenue reached $543M, with continued expansion expected in 2024. Operational adjustments and strategic investments support ongoing growth and efficiency.
-
Second quarter revenue rose 2% year-over-year, but EBITDA and EPS declined due to higher SG&A and supply chain delays. Full-year guidance is maintained, with delayed revenue expected to be recovered in the third quarter and strong pipelines supporting second-half acceleration.
-
Three business segments—healthcare apparel, branded products, and contact centers—are driving growth through digital expansion, new product launches, and strong customer retention. 2024 guidance calls for continued revenue growth, improved margins, and a focus on organic opportunities over acquisitions.